Ira Mellman

25PUBLICATIONS
150CO-AUTHORS
Molecular targetsInnate immunityChemical and thermal processes in energy and combustionApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Semi- and unsupervised learning
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (25)

|Feb 19, 2025
RNA neoantigen vaccines prime long-lived CD8+ T cells in pancreatic cancer.

Zachary Sethna, Pablo Guasp, Charlotte Reiche

|Jan 24, 2025
Different PD-L1 Assays Reveal Distinct Immunobiology and Clinical Outcomes in Urothelial Cancer.

Matthew D Galsky, Mark Kockx, Juliette Roels

|Dec 16, 2024
TIGIT and PD-L1 co-blockade promotes clonal expansion of multipotent, non-exhausted antitumor T cells by facilitating co-stimulation.

Katherine Nutsch, Karl L Banta, Thomas D Wu

|Mar 15, 2024
The Exonuclease TREX1 Constitutes an Innate Immune Checkpoint Limiting cGAS/STING-Mediated Antitumor Immunity.

Junghyun Lim, Ryan Rodriguez, Katherine Williams

|Feb 28, 2024
Anti-TIGIT antibody improves PD-L1 blockade through myeloid and Treg cells.

Xiangnan Guan, Ruozhen Hu, Yoonha Choi

|Dec 14, 2023
Nucleotide modifications enable rational design of TLR7-selective ligands by blocking RNase cleavage.

Ann-Jay Tong, Rebecca Leylek, Anna-Maria Herzner

Pageof 5

Frequent Collaborators

6 joint publications

Robert J Johnston

6 joint publications

Barzin Y Nabet

4 joint publications

Katherine Williams

4 joint publications

David S Shames